Find your next paid study

Abramson Cancer Center at Penn MedicineNCT07454499

Actual pay is set by the research site.

Phase 3

A Randomized, Double-blind, Parallel Group Phase 3 Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (PERSIST CRSwNP-2)

The aim of this study is to assess the efficacy and safety of GSK5784283 administered as add-on maintenance therapy to participants with CRSwNP.

Nasal Polyps

GlaxoSmithKlineNCT07782957

~$50 – $2,250

Actual pay is set by the research site.

Metastatic Pancreatic Adenocarcinoma

A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma

The goal of this clinical research study is to learn about the safety and tolerability of the OnVagus device when used by patients who have metastatic pancreat…

M.D. Anderson Cancer CenterNCT07700212

~$150 – $3,000

Actual pay is set by the research site.

Registry of Patients With Bone Disorders

The purpose of this study is to create an electronic registry to house phenotypic information from patients with achondroplasia. The initial focus of this regi…

Achondroplasia

Johns Hopkins UniversityNCT02597881

Actual pay is set by the research site.

Phase 2

A Randomized Phase 2/3 Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma (HARMONi-GU1)

A Randomized, Open-Label, Multicenter, Phase 2/3 Clinical Study of Ivonescimab in Combination with Enfortumab Vedotin vs Pembrolizumab in Combination with Enfo…

Metastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma (UC)

Summit TherapeuticsNCT07815665

~$75 – $2,800

Actual pay is set by the research site.

Geographic AtrophyStargardt DiseaseRPE-mediated Maculopathy+1 more

A Phase I Single-Center Open-label Study of C.001 in Patients With Significant Retinal Pigment Epithelium Mediated Maculopathy (RMM)

This is a first-in-human Phase 1 study evaluating the safety and tolerability of C.001 in patients with retinal diseases involving degeneration of the retinal …

Cellio Therapeutics IncNCT07594236

~$150 – $4,200

Actual pay is set by the research site.

Observational

StableEyes With Active Neurophysiological Feedback

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness…

Vestibular DisorderVestibular SchwannomaSpace Motion Sickness+1 more

Johns Hopkins UniversityNCT05622344

Actual pay is set by the research site.

Observational

Implementation of a Clinical Decision Support Tool for Postpartum Depression

This study will evaluate the use of an automated process in the electronic health record (EHR) that will help providers to detect patients at risk of developin…

Postpartum Depression

Weill Medical College of Cornell UniversityNCT06818734

Actual pay is set by the research site.

Phase 4

SAVE-Care (SGLT2i As Novel Gout Care) Trial

SAVE-Care (Sodium Glucose Cotransporter-2 inhibitors \[SGLT2i\] As Novel Gout Care) Trial is a double-blind randomized placebo-controlled trial (RCT) designed …

Gout and Hyperuricemia

Massachusetts General HospitalNCT06674109

~$25 – $1,000

Actual pay is set by the research site.

Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more

A Phase 1, Multicenter, Open-Label, Dose-Escalation Study to Assess Safety, Tolerability, and Efficacy of EXS74539 as Monotherapy in Participants With Select Solid Tumors

The primary purpose of this study is to determine the safety, tolerability, and maximum tolerated dose (MTD) of EXS74539 (REC-4539) in participants with select…

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

~$150 – $4,200

Actual pay is set by the research site.

GBE Deficiency (GSD IV and APBD) Natural History Study

Collection and review of clinical information related to glycogen branching enzyme (GBE) deficiency, diagnosed as Glycogen Storage Disease Type IV (GSD IV) or …

Glycogen Storage Disease Type IVAdult Polyglucosan Body DiseaseGSD4+2 more

Duke UniversityNCT02683512

Actual pay is set by the research site.

A Phase I/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A830 in Solid Tumors

This is a first-in-human (FIH), multicenter, open-label, phase I/Ⅱa clinical study of HMPL-A830 in participants with histologically or cytologically confirmed,…

Solid Tumor, Adult